Pharma Journalist - Page 885 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

GB Sciences Files Patent Application for Chronic Pain and Heart Therapies based on MCCM

AstraZeneca selects DNAnexus’s cloud based platform for CGR

Atox Bio: Reltecimod passes Futility Analysis and will continue Phase 3

Tom Privette Joins Acurian as VP and head of global Business Development

Debiopharm International acquires clinical-stage ADC, ImmunoGen’s IMGN529/Debio 1562

Palladio Biosciences acquires global rights to develop Lixivaptan

CROS NT Extend Medidata pact to deploy Medidata’s next-gen EDC and RTSM systems

Worldwide Clinical Trials appoints Karen Nowatkoski Clinical operations VP

Tekni-Plex announces acquisition of BrunaSeals

Astrazeneca sells Seloken European rights to Recordati